跳至主要内容
临床试验/NCT00676637
NCT00676637已完成不适用

A Pilot Study of Adherence Assessment With the Travalert™ Dosing Aid in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma Who Are Treated With the Travoprost/Timolol Maleate Fixed Combination Every Evening

Alcon Research4 个研究点 分布在 4 个国家目标入组 55 人开始时间: 2008年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
55
试验地点
4
主要终点
Mean Change from Baseline in Intraocular Pressure at 4 months

研究概览

简要总结

The purpose of this study is evaluate adherence to DuoTrav® when reinforced by the use of the Travalert™ Dosing Aid.

详细描述

This study was conducted in France, UK, Italy, and Netherlands. An identical study was conducted in Spain under Protocol ID EMD-07-02. A combined enrollment number is presented.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Travalert with DuoTrav

One drop in study eye(s) once daily in the evening for four months

干预措施: Travoprost 0.004%/timolol 0.05% fixed combination eye drops (DuoTrav) (Drug)

Travalert with DuoTrav

One drop in study eye(s) once daily in the evening for four months

干预措施: Travalert Dosing Aid (Device)

结局指标

主要结局

Mean Change from Baseline in Intraocular Pressure at 4 months

时间窗: Baseline, 4 months

As measured by Goldmann applanation tonometry

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验